Slfn4 inhibitors belong to a specific category of chemical compounds designed to target and inhibit the activity of the Slfn4 protein, also known as Schlafen 4. Slfn4 is a member of the Schlafen family of proteins, which are involved in various cellular processes, including regulation of cell cycle progression, immune response modulation, and antiviral activity. These proteins have gained attention due to their roles in cellular growth control and immune regulation. Inhibitors of Slfn4 are primarily developed for research purposes, serving as essential tools for scientists and researchers to investigate the molecular mechanisms and functions associated with this protein in the context of cellular growth and immune responses.
Typically, Slfn4 inhibitors are composed of small molecules or chemical compounds specifically designed to interact with the Slfn4 protein, disrupting its normal function. By inhibiting Slfn4, these compounds can potentially affect cellular processes related to cell cycle regulation and immune response modulation, providing insights into the consequences of such disruptions on cell behavior and immune function. Researchers use Slfn4 inhibitors in laboratory settings to manipulate the activity of this protein and study its roles in cell growth control and immune regulation. These inhibitors provide valuable insights into the molecular mechanisms by which Slfn4 influences cellular processes and contribute to a deeper understanding of its significance in cellular biology. While Slfn4 inhibitors may have broader implications, their primary purpose is to assist scientists in deciphering the intricacies of Slfn4-mediated cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation, potentially impacting the expression of proteins like Slfn4. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, altering gene expression patterns which may include genes like SLFN4. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, which can change chromatin structure and influence gene expression, possibly affecting Slfn4. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is known to interact with multiple molecular targets, which could potentially impact the expression of proteins like Slfn4. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib targets multiple kinases, potentially affecting signaling pathways that regulate gene expression, including SLFN4. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin influences AMPK and other signaling pathways, which might affect the expression of genes like SLFN4. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits proteasome activity, which can lead to altered protein levels and gene expression, potentially affecting Slfn4. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates DNA and inhibits topoisomerase II, which can disrupt gene expression patterns, including SLFN4. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, affecting DNA synthesis and potentially altering gene expression, including that of SLFN4. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide modulates various signaling pathways and affects gene expression, which could potentially impact Slfn4 levels. | ||||||